NYX-2925 is a novel NMDA receptor-specific spirocyclic-β-lactam that modulates synaptic plasticity processes associated with learning and memory (Q47383734)
Jump to navigation
Jump to search
scientific article published in November 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NYX-2925 is a novel NMDA receptor-specific spirocyclic-β-lactam that modulates synaptic plasticity processes associated with learning and memory |
scientific article published in November 2017 |
Statements
NYX-2925 is a novel NMDA receptor-specific spirocyclic-β-lactam that modulates synaptic plasticity processes associated with learning and memory (English)
1 reference
M Amin Khan
1 reference
David R Houck
1 reference
Amanda L Gross
1 reference
Xiao-Lei Zhang
1 reference
Cassia Cearley
1 reference
Torsten M Madsen
1 reference
Roger A Kroes
1 reference
Patric K Stanton
1 reference
Jeffrey Burgdorf
1 reference
Joseph R Moskal
1 reference
1 March 2018
1 reference
21
1 reference
3
1 reference
242-254
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference